CYP3A4 and non-small cell lung carcinoma: Vinorelbine is one of the alkaloid chemotherapeutic drugs with curative effects for non-small cell lung cancer patients [25,26], which promotes cell death mainly by disturbing the microtubule dynamics [25], and whose metabolism is mainly conducted in the liver, and mainly catalyzed by CYP3A4 [27].